Publications
44
Citations
1,351
Est. group size
—
Recurring co-author estimate
Active years
20
Publishing since 2007
Typically publishes in teams of ~6 · 29% small-team papers (≤3 authors) · across 26 venues
- Abstract 3623: Effects of the anti-obesity medication tirzepatide on the tumor microenvironment in a mouse model of obesity-associated, hormone-dependent breast cancer
Cancer Research · 2026
- Evaluating a novel tool for screening pediatric aspiration and penetration risk: Considerations for safe and effective dysphagia screening in children
Developmental Medicine & Child Neurology · 2025
- Abstract RF3-05: A Phase 2 Study of Neoadjuvant HER2-targeted Therapy +/- Immunotherapy with Pembrolizumab (neoHIP)
Clinical Cancer Research · 2025
- Positional Therapy for the Treatment of Obstructive Sleep Apnea in Children: A Qualitative Study
American Journal of Respiratory and Critical Care Medicine · 2025
- SAT-291 Impact of the Incretin Mimetic Drug Tirzepatide on Obesity-Associated Breast Cancer Growth: Findings from a Preclinical Model
Journal of the Endocrine Society · 2025
- Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center
npj Breast Cancer · 2024
- How does the Surgical Repair of Ptosis Impact Refractive Error?
Journal of Binocular Vision and Ocular Motility · 2024
- Abstract 4147376: Leveraging Telemedicine to Assess Care Quality Among Rural-Residing Patients with Heart Failure: The Rural-HF Registry
Circulation · 2024
- Attitudes and personal beliefs about the COVID-19 vaccine among people with COVID-19: a mixed-methods analysis
BMC Public Health · 2022
- Abstract OT1-18-03: The neoIRX trial:locoregional cytokine therapy to promote immunologic priming and enhanced response to neoadjuvant pembrolizumab plus chemotherapy in triple negative breast cancer (TNBC)
Cancer Research · 2022
- Abstract P5-14-02: Breast cancer clinical trial participation rate among patients of low socioeconomic status at a comprehensive cancer center
Cancer Research · 2022
- Evaluating patient risk factors associated with low rates of breast cancer clinical trial accrual.
Journal of Clinical Oncology · 2022
- Evaluating factors contributing to low rates of breast cancer clinical trial accrual in a diverse patient population.
Journal of Clinical Oncology · 2022
- Managing the child born preterm after hospital discharge
Speech Language and Hearing · 2022
- Is children’s speech development changing? Preliminary evidence from Australian English-speaking 3-year-olds
International Journal of Speech-Language Pathology · 2021
- Acta Paediatrica×4
- Cancer Research×3
- Developmental Medicine & Child Neurology×2
- Early Human Development×2
- Evidence-Based Communication Assessment and Intervention×2
- Jenn Gonya
Medicine · The Ohio State University
- Abbey C. Hines
Medicine · Indiana University
- Christine A. Fortney
Medicine · The Ohio State University
- Carol B. Jaeger
Medicine · The Ohio State University
- Marin Arnolds
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile